{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:33:41Z","timestamp":1792683221738,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"26","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,7,14]]},"DOI":"10.1038\/s41388-025-03380-6","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T01:00:36Z","timestamp":1744333236000},"page":"2158-2169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder"],"prefix":"10.1038","volume":"44","author":[{"given":"Chia-Hao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit L.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Molony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Silvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Mahmudul Hasan","family":"Akash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Messing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7766-6738","authenticated-orcid":false,"given":"Yi-Fen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"3380_CR1","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/cncr.22224","volume":"107","author":"EM Messing","year":"2006","unstructured":"Messing EM, Madeb R, Young T, Gilchrist KW, Bram L, Greenberg EB, et al. Long-term outcome of hematuria home screening for bladder cancer in men. Cancer. 2006;107:2173\u20139.","journal-title":"Cancer"},{"key":"3380_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cncr.23986","volume":"115","author":"E Scosyrev","year":"2009","unstructured":"Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009;115:68\u201374.","journal-title":"Cancer"},{"key":"3380_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.biopha.2007.05.004","volume":"61","author":"S Brandau","year":"2007","unstructured":"Brandau S, Suttmann H. Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. Biomedicine Pharmacother = Biomedecine Pharmacotherapie. 2007;61:299\u2013305.","journal-title":"Biomedicine Pharmacother = Biomedecine Pharmacotherapie"},{"key":"3380_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-pathol-012513-104703","volume":"11","author":"B Czerniak","year":"2016","unstructured":"Czerniak B, Dinney C, McConkey D. Origins of bladder cancer. Annu Rev Pathol. 2016;11:149\u201374.","journal-title":"Annu Rev Pathol"},{"key":"3380_CR5","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-05-0891","volume":"11","author":"TD Jones","year":"2005","unstructured":"Jones TD, Wang M, Eble JN, MacLennan GT, Lopez-Beltran A, Zhang S, et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res. 2005;11:6512\u20139.","journal-title":"Clin Cancer Res"},{"key":"3380_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5858\/2004-128-187-ALOTAX","volume":"128","author":"L Cheng","year":"2004","unstructured":"Cheng L, MacLennan GT, Pan CX, Jones TD, Moore CR, Zhang S, et al. Allelic loss of the active X chromosome during bladder carcinogenesis. Arch Pathol Lab Med. 2004;128:187\u201390.","journal-title":"Arch Pathol Lab Med"},{"key":"3380_CR7","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S0002-9440(10)62369-3","volume":"166","author":"L Cheng","year":"2005","unstructured":"Cheng L, Jones TD, McCarthy RP, Eble JN, Wang M, MacLennan GT, et al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol. 2005;166:1533\u20139.","journal-title":"Am J Pathol"},{"key":"3380_CR8","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507:315\u201322.","DOI":"10.1038\/nature12965"},{"key":"3380_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1586\/era.10.73","volume":"10","author":"L Cheng","year":"2010","unstructured":"Cheng L, Davidson DD, Maclennan GT, Williamson SR, Zhang S, Koch MO, et al. The origins of urothelial carcinoma. Expert Rev Anticancer Ther. 2010;10:865\u201380.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3380_CR10","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nrc1505","volume":"4","author":"Y Ma","year":"2004","unstructured":"Ma Y, Hendershot LM. The role of the unfolded protein response in tumour development: friend or foe?. Nat Rev Cancer. 2004;4:966\u201377.","journal-title":"Nat Rev Cancer"},{"key":"3380_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nature Rev Mol Cell Biol. 2012;13:89\u2013102.","journal-title":"Nature Rev Mol Cell Biol"},{"key":"3380_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrc3800","volume":"14","author":"M Wang","year":"2014","unstructured":"Wang M, Kaufman RJ. The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer. 2014;14:581\u201397.","journal-title":"Nat Rev Cancer"},{"key":"3380_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ccr.2014.03.015","volume":"25","author":"HJ Clarke","year":"2014","unstructured":"Clarke HJ, Chambers JE, Liniker E, Marciniak SJ. Endoplasmic reticulum stress in malignancy. Cancer Cell. 2014;25:563\u201373.","journal-title":"Cancer Cell"},{"key":"3380_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1158\/2159-8290.CD-14-1490","volume":"5","author":"E Chevet","year":"2015","unstructured":"Chevet E, Hetz C, Samali A. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov. 2015;5:586\u201397.","journal-title":"Cancer Discov"},{"key":"3380_CR15","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.ajpath.2020.01.010","volume":"190","author":"SA Oakes","year":"2020","unstructured":"Oakes SA. Endoplasmic reticulum stress signaling in cancer cells. American J Pathol. 2020;190:934\u201346.","journal-title":"American J Pathol"},{"key":"3380_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.trecan.2016.03.007","volume":"2","author":"H Urra","year":"2016","unstructured":"Urra H, Dufey E, Avril T, Chevet E, Hetz C. Endoplasmic Reticulum Stress and the Hallmarks of Cancer. Trends Cancer. 2016;2:252\u201362.","journal-title":"Trends Cancer"},{"key":"3380_CR17","doi-asserted-by":"publisher","first-page":"114737","DOI":"10.1016\/j.bcp.2021.114737","volume":"192","author":"D Liang","year":"2021","unstructured":"Liang D, Khoonkari M, Avril T, Chevet E, Kruyt FA. The unfolded protein response as regulator of cancer stemness and differentiation: Mechanisms and implications for cancer therapy. Biochemical Pharmacol. 2021;192:114737.","journal-title":"Biochemical Pharmacol"},{"key":"3380_CR18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1096\/fasebj.7.15.7903263","volume":"7","author":"CC Wang","year":"1993","unstructured":"Wang CC, Tsou CL. Protein disulfide isomerase is both an enzyme and a chaperone. FASEB J. 1993;7:1515\u20137.","journal-title":"FASEB J"},{"key":"3380_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.freeradbiomed.2015.02.007","volume":"83","author":"L Wang","year":"2015","unstructured":"Wang L, Wang X, Wang C-C. Protein disulfide\u2013isomerase, a folding catalyst and a redox-regulated chaperone. Free Radic Biol Med. 2015;83:305\u201313.","journal-title":"Free Radic Biol Med"},{"key":"3380_CR20","doi-asserted-by":"publisher","first-page":"e103841","DOI":"10.15252\/embj.2019103841","volume":"39","author":"J Yu","year":"2020","unstructured":"Yu J, Li T, Liu Y, Wang X, Zhang J, Wang XE, et al. Phosphorylation switches protein disulfide isomerase activity to maintain proteostasis and attenuate ER stress. EMBO J. 2020;39:e103841.","journal-title":"EMBO J"},{"key":"3380_CR21","doi-asserted-by":"publisher","first-page":"107525","DOI":"10.1016\/j.pharmthera.2020.107525","volume":"210","author":"AG Shergalis","year":"2020","unstructured":"Shergalis AG, Hu S, Bankhead III A, Neamati N. Role of the ERO1-PDI interaction in oxidative protein folding and disease. Pharmacology therapeutics. 2020;210:107525.","journal-title":"Pharmacology therapeutics"},{"key":"3380_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.freeradbiomed.2015.01.011","volume":"83","author":"E Zito","year":"2015","unstructured":"Zito E. ERO1: A protein disulfide oxidase and H2O2 producer. Free Radic Biol Med. 2015;83:299\u2013304.","journal-title":"Free Radic Biol Med"},{"key":"3380_CR23","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3389\/fonc.2020.01613","volume":"10","author":"L Lyu","year":"2020","unstructured":"Lyu L, Xiang W, Zheng F, Huang T, Feng Y, Yuan J, et al. Significant prognostic value of the autophagy-related gene P4HB in bladder urothelial carcinoma. Frontiers Oncol. 2020;10:1613.","journal-title":"Frontiers Oncol"},{"key":"3380_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2020.12278","volume":"21","author":"Y Wu","year":"2021","unstructured":"Wu Y, Peng Y, Guan B, He A, Yang K, He S, et al. P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma. Oncology Lett. 2021;21:1.","journal-title":"Oncology Lett"},{"key":"3380_CR25","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.2147\/OTT.S267734","volume":"13","author":"X Wang","year":"2020","unstructured":"Wang X, Bai Y, Zhang F, Yang Y, Feng D, Li A. et al. Targeted inhibition of P4HB promotes cell sensitivity to gemcitabine in Urothelial carcinoma of the bladder. OncoTarget Therapy. 2020;13:9543\u201358.","journal-title":"OncoTarget Therapy"},{"key":"3380_CR26","doi-asserted-by":"publisher","first-page":"1253586","DOI":"10.3389\/fimmu.2023.1253586","volume":"14","author":"S Xiong","year":"2023","unstructured":"Xiong S, Li S, Zeng J, Nie J, Liu T, Liu X. et al. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB. Front Immunol. 2023;14:1253586","journal-title":"Front Immunol"},{"key":"3380_CR27","doi-asserted-by":"publisher","first-page":"e2986","DOI":"10.1038\/cddis.2017.369","volume":"8","author":"P Kranz","year":"2017","unstructured":"Kranz P, Neumann F, Wolf A, Classen F, Pompsch M, Ocklenburg T, et al. PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR). Cell Death Dis. 2017;8:e2986.","journal-title":"Cell Death Dis"},{"key":"3380_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1189\/jlb.0610324","volume":"90","author":"APAM de","year":"2011","unstructured":"de APAM, Verissimo-Filho S, Guimaraes LL, Silva AC, Takiuti JT, Santos CX, et al. Protein disulfide isomerase redox-dependent association with p47(phox): evidence for an organizer role in leukocyte NADPH oxidase activation. J Leukoc Biol. 2011;90:799\u2013810.","journal-title":"J Leukoc Biol"},{"key":"3380_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.abb.2009.01.022","volume":"484","author":"DC Fernandes","year":"2009","unstructured":"Fernandes DC, Manoel AH, Wosniak J Jr, Laurindo FR. Protein disulfide isomerase overexpression in vascular smooth muscle cells induces spontaneous preemptive NADPH oxidase activation and Nox1 mRNA expression: effects of nitrosothiol exposure. Arch Biochem Biophys. 2009;484:197\u2013204.","journal-title":"Arch Biochem Biophys"},{"key":"3380_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.juro.2014.02.035","volume":"192","author":"CJ Beckham","year":"2014","unstructured":"Beckham CJ, Olsen J, Yin PN, Wu CH, Ting HJ, Hagen FK, et al. Bladder cancer exosomes contain EDIL-3\/Del1 and facilitate cancer progression. Journal Urol. 2014;192:583\u201392.","journal-title":"Journal Urol"},{"key":"3380_CR31","doi-asserted-by":"publisher","first-page":"23335","DOI":"10.18632\/oncotarget.8024","volume":"7","author":"CR Silvers","year":"2016","unstructured":"Silvers CR, Liu YR, Wu CH, Miyamoto H, Messing EM, Lee YF. Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer. Oncotarget. 2016;7:23335\u201345.","journal-title":"Oncotarget"},{"key":"3380_CR32","doi-asserted-by":"publisher","first-page":"91199","DOI":"10.18632\/oncotarget.20043","volume":"8","author":"CR Silvers","year":"2017","unstructured":"Silvers CR, Miyamoto H, Messing EM, Netto GJ, Lee YF. Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer. Oncotarget. 2017;8:91199\u2013208.","journal-title":"Oncotarget"},{"key":"3380_CR33","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1074\/jbc.RA118.006682","volume":"294","author":"C-H Wu","year":"2019","unstructured":"Wu C-H, Silvers CR, Messing EM, Lee Y-F. Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of nonmalignant cells. Journal Biol Chem. 2019;294:3207\u201318.","journal-title":"Journal Biol Chem"},{"key":"3380_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/cbin.11730","volume":"46","author":"B Fu","year":"2022","unstructured":"Fu B, Ma H, Zhang DJ, Wang L, Li ZQ, Guo ZH, et al. Porcine oviductal extracellular vesicles facilitate early embryonic development via relief of endoplasmic reticulum stress. Cell Biol Int. 2022;46:300\u201310.","journal-title":"Cell Biol Int"},{"key":"3380_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fimmu.2014.00403","volume":"5","author":"F Baixauli","year":"2014","unstructured":"Baixauli F, L\u00f3pez-Ot\u00edn C, Mittelbrunn M. Exosomes and autophagy: coordinated mechanisms for the maintenance of cellular fitness. Front Immunol. 2014;5:403.","journal-title":"Front Immunol"},{"key":"3380_CR36","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.15252\/embj.201696139","volume":"36","author":"J Fan","year":"2017","unstructured":"Fan J, Kuai B, Wu G, Wu X, Chi B, Wang L, et al. Exosome cofactor hMTR4 competes with export adaptor ALYREF to ensure balanced nuclear RNA pools for degradation and export. Embo j. 2017;36:2870\u201386.","journal-title":"Embo j"},{"key":"3380_CR37","doi-asserted-by":"publisher","first-page":"100261","DOI":"10.1016\/j.impact.2020.100261","volume":"20","author":"S Fu","year":"2020","unstructured":"Fu S, Wang Y, Xia X, Zheng JC. Exosome engineering: Current progress in cargo loading and targeted delivery. NanoImpact. 2020;20:100261.","journal-title":"NanoImpact"},{"key":"3380_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.dnarep.2014.01.003","volume":"15","author":"M Yasui","year":"2014","unstructured":"Yasui M, Kanemaru Y, Kamoshita N, Suzuki T, Arakawa T, Honma M. Tracing the fates of site-specifically introduced DNA adducts in the human genome. DNA Repair (Amst). 2014;15:11\u201320.","journal-title":"DNA Repair (Amst)"},{"key":"3380_CR39","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2018","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2018;47:D941\u2013D7.","journal-title":"Nucleic Acids Res"},{"key":"3380_CR40","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2019.03.001","volume":"177","author":"JE Kucab","year":"2019","unstructured":"Kucab JE, Zou X, Morganella S, Joel M, Nanda AS, Nagy E, et al. A Compendium of Mutational Signatures of Environmental Agents. Cell. 2019;177:821\u201336.e16.","journal-title":"Cell"},{"key":"3380_CR41","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.18632\/oncotarget.23344","volume":"9","author":"AP Glaser","year":"2018","unstructured":"Glaser AP, Fantini D, Wang Y, Yu Y, Rimar KJ, Podojil JR, et al. APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response. Oncotarget. 2018;9:4537\u201348.","journal-title":"Oncotarget"},{"key":"3380_CR42","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1074\/jbc.REV118.002804","volume":"294","author":"KFR Pobre","year":"2019","unstructured":"Pobre KFR, Poet GJ, Hendershot LM. The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: Getting by with a little help from ERdj friends. Journal Biol Chem. 2019;294:2098\u2013108.","journal-title":"Journal Biol Chem"},{"key":"3380_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fcell.2015.00030","volume":"3","author":"S Parakh","year":"2015","unstructured":"Parakh S, Atkin JD. Novel roles for protein disulphide isomerase in disease states: a double edged sword?. Front Cell Dev Biol. 2015;3:30.","journal-title":"Front Cell Dev Biol"},{"key":"3380_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0962-8924(00)01745-1","volume":"10","author":"AR Frand","year":"2000","unstructured":"Frand AR, Cuozzo JW, Kaiser CA. Pathways for protein disulphide bond formation. Trends Cell Biol. 2000;10:203\u201310.","journal-title":"Trends Cell Biol"},{"key":"3380_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbrc.2016.10.019","volume":"480","author":"S Kanemoto","year":"2016","unstructured":"Kanemoto S, Nitani R, Murakami T, Kaneko M, Asada R, Matsuhisa K, et al. Multivesicular body formation enhancement and exosome release during endoplasmic reticulum stress. Biochemical Biophysical Res Commun. 2016;480:166\u201372.","journal-title":"Biochemical Biophysical Res Commun"},{"key":"3380_CR46","doi-asserted-by":"publisher","first-page":"3553617.","DOI":"10.1155\/2022\/3553617","volume":"2022","author":"W Zhang","year":"2022","unstructured":"Zhang W, Liu R, Chen Y, Wang M, Du J. Crosstalk between oxidative stress and exosomes. Oxidat Med Cell Longevity. 2022;2022:3553617.","journal-title":"Oxidat Med Cell Longevity"},{"key":"3380_CR47","doi-asserted-by":"publisher","first-page":"8186","DOI":"10.1080\/21655979.2021.1977767","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhao Y, Yin Y, Jia X, Mao L. Mechanism of cargo sorting into small extracellular vesicles. Bioengineered. 2021;12:8186\u2013201.","journal-title":"Bioengineered"},{"key":"3380_CR48","first-page":"e120","volume":"3","author":"K Waury","year":"2024","unstructured":"Waury K, Gogishvili D, Nieuwland R, Chatterjee M, Teunissen CE, Abeln S. Proteome encoded determinants of protein sorting into extracellular vesicles. Journal Extracell Biol. 2024;3:e120.","journal-title":"Journal Extracell Biol"},{"key":"3380_CR49","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ajhg.2014.12.027","volume":"96","author":"F Rauch","year":"2015","unstructured":"Rauch F, Fahiminiya S, Majewski J, Carrot-Zhang J, Boudko S, Glorieux F, et al. Cole-Carpenter syndrome is caused by a heterozygous missense mutation in P4HB. Am J Hum Genet. 2015;96:425\u201331.","journal-title":"Am J Hum Genet"},{"key":"3380_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11060-007-9457-5","volume":"86","author":"Y Liang","year":"2008","unstructured":"Liang Y, Diehn M, Bollen AW, Israel MA, Gupta N. Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment. J Neurooncol. 2008;86:133\u201341.","journal-title":"J Neurooncol"},{"key":"3380_CR51","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.bbrc.2017.11.186","volume":"495","author":"M Popielarski","year":"2018","unstructured":"Popielarski M, Ponamarczuk H, Stasiak M, Michalec L, Bednarek R, Studzian M, et al. The role of Protein Disulfide Isomerase and thiol bonds modifications in activation of integrin subunit alpha11. Biochem Biophys Res Commun. 2018;495:1635\u201341.","journal-title":"Biochem Biophys Res Commun"},{"key":"3380_CR52","doi-asserted-by":"publisher","first-page":"118663","DOI":"10.1016\/j.bbamcr.2020.118663","volume":"1867","author":"F Baltes","year":"2020","unstructured":"Baltes F, Pfeifer V, Silbermann K, Caspers J, Wantoch von Rekowski K, Schlesinger M, et al. \u03b2(1)-Integrin binding to collagen type 1 transmits breast cancer cells into chemoresistance by activating ABC efflux transporters. Biochim Biophys Acta Mol Cell Res. 2020;1867:118663.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3380_CR53","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3892\/or.2020.7816","volume":"44","author":"R Alhammad","year":"2020","unstructured":"Alhammad R, Khunchai S, Tongmuang N, Limjindaporn T, Yenchitsomanus PT, Mutti L, et al. Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state. Oncology Rep. 2020;44:2406\u201318.","journal-title":"Oncology Rep"},{"key":"3380_CR54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biochi.2015.01.006","volume":"110","author":"IH Chen","year":"2015","unstructured":"Chen IH, Chang FR, Wu YC, Kung PH, Wu CC. 3,4-Methylenedioxy-\u03b2-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing \u03b21 integrin function and surface protein disulfide isomerase. Biochimie. 2015;110:81\u201392.","journal-title":"Biochimie"},{"key":"3380_CR55","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/ijms20040821","volume":"20","author":"E Oeyen","year":"2019","unstructured":"Oeyen E, Hoekx L, De Wachter S, Baldewijns M, Ameye F, Mertens I. Bladder cancer diagnosis and follow-up: the current status and possible role of extracellular vesicles. International J Mol Sci. 2019;20:821.","journal-title":"International J Mol Sci"},{"key":"3380_CR56","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3390\/cancers12061400","volume":"12","author":"Oliveira MCd","year":"2020","unstructured":"MCd Oliveira, Caires HR, Oliveira MJ, Fraga A, Vasconcelos MH, Ribeiro R. Urinary biomarkers in bladder cancer: where do we stand and potential role of extracellular vesicles. Cancers. 2020;12:1400.","journal-title":"Cancers"},{"key":"3380_CR57","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.3390\/ijms19092822","volume":"19","author":"Y-R Liu","year":"2018","unstructured":"Liu Y-R, Ortiz-Bonilla CJ, Lee Y-F. Extracellular vesicles in bladder cancer: biomarkers and beyond. International J Mol Sci. 2018;19:2822.","journal-title":"International J Mol Sci"},{"key":"3380_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5213\/inj.1734961.458","volume":"21","author":"J-Y Choi","year":"2017","unstructured":"Choi J-Y, Kim S, Kwak H-B, Park D-H, Park J-H, Ryu J-S, et al. Extracellular vesicles as a source of urological biomarkers: lessons learned from advances and challenges in clinical applications to major diseases. International Neurourol J. 2017;21:83.","journal-title":"International Neurourol J"},{"key":"3380_CR59","doi-asserted-by":"publisher","first-page":"e22914","DOI":"10.1096\/fj.202201952R","volume":"37","author":"JA Gelzinis","year":"2023","unstructured":"Gelzinis JA, Szahaj MK, Bekendam RH, Wurl SE, Pantos MM, Verbetsky CA, et al. Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic. FASEB J: Off Publ Federation Am Societies Exp Biol. 2023;37:e22914.","journal-title":"FASEB J: Off Publ Federation Am Societies Exp Biol"},{"key":"3380_CR60","doi-asserted-by":"publisher","first-page":"111906","DOI":"10.1016\/j.ejmech.2019.111906","volume":"186","author":"RM Robinson","year":"2020","unstructured":"Robinson RM, Reyes L, Duncan RM, Bian H, Strobel ED, Hyman SL, et al. Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitor. European J medicinal Chem. 2020;186:111906.","journal-title":"European J medicinal Chem"},{"key":"3380_CR61","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1002\/cam4.3836","volume":"10","author":"LE Powell","year":"2021","unstructured":"Powell LE, Foster PA. Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy. Cancer Med. 2021;10:2812\u201325.","journal-title":"Cancer Med"},{"key":"3380_CR62","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbrc.2018.05.001","volume":"501","author":"H Kazama","year":"2018","unstructured":"Kazama H, Hiramoto M, Miyahara K, Takano N, Miyazawa K. Designing an effective drug combination for ER stress loading in cancer therapy using a real-time monitoring system. Biochem Biophys Res Commun. 2018;501:286\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"3380_CR63","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1038\/s41598-023-33140-z","volume":"13","author":"X Yu","year":"2023","unstructured":"Yu X, Li W, Feng Y, Gao Z, Wu Q, Xia Y. The prognostic value of hedgehog signaling in bladder cancer by integrated bioinformatics. Scientific Rep. 2023;13:6241.","journal-title":"Scientific Rep"},{"key":"3380_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11934-015-0568-9","volume":"17","author":"IS Syed","year":"2016","unstructured":"Syed IS, Pedram A, Farhat WA. Role of sonic hedgehog (Shh) signaling in bladder cancer stemness and tumorigenesis. Current Urol Rep. 2016;17:1\u20137.","journal-title":"Current Urol Rep"},{"key":"3380_CR65","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12859-018-2234-y","volume":"19","author":"M D\u00edaz-Gay","year":"2018","unstructured":"D\u00edaz-Gay M, Vila-Casades\u00fas M, Franch-Exp\u00f3sito S, Hern\u00e1ndez-Ill\u00e1n E, Lozano JJ, Castellv\u00ed-Bel S. Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples. BMC Bioinforma. 2018;19:224.","journal-title":"BMC Bioinforma"},{"key":"3380_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13073-018-0539-0","volume":"10","author":"F Blokzijl","year":"2018","unstructured":"Blokzijl F, Janssen R, van Boxtel R, Cuppen E. MutationalPatterns: comprehensive genome-wide analysis of mutational processes. Genome Med. 2018;10:33.","journal-title":"Genome Med"},{"key":"3380_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1440-1827.2009.02477.x","volume":"60","author":"H Miyamoto","year":"2010","unstructured":"Miyamoto H, Miller JS, Fajardo DA, Lee TK, Netto GJ, Epstein JI. Non-invasive papillary urothelial neoplasms: the 2004 WHO\/ISUP classification system. Pathol Int. 2010;60:1\u20138.","journal-title":"Pathol Int"},{"key":"3380_CR68","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/j.1464-410X.2011.10706.x","volume":"109","author":"H Miyamoto","year":"2012","unstructured":"Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, et al. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int. 2012;109:1716\u201326.","journal-title":"BJU Int"},{"key":"3380_CR69","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"3380_CR70","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","volume":"224","author":"S Bolte","year":"2006","unstructured":"Bolte S, Cordeli\u00e8res FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224:213\u201332.","journal-title":"J Microsc"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03380-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03380-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03380-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T18:02:26Z","timestamp":1750615346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03380-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":70,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2025,7,14]]}},"alternative-id":["3380"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03380-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4425743\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Approval was obtained from the Research Subjects Review Board, the University of Rochester\u2019s Institutional Review Board under STUDY00005593 prior to the construction and use of the Tissue Microarray. Informed consent was obtained from the subjects prior to the tissue collection. All specimens were de-identified to use and no patient identifiers are included in the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}